# Bioequivalence Evaluation of Two Film-Coated Formulations of Valsartan 160 mg

> **NCT02518451** · NA · COMPLETED · sponsor: **Dexa Medica Group** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Valsartan 160 mg film-coated caplets (test formulation)
- **DRUG:** Valsartan 160 mg film-coated caplets (reference formulation)

## Key facts

- **NCT ID:** NCT02518451
- **Lead sponsor:** Dexa Medica Group
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2013-10
- **Final completion:** 2014-03
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2015-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02518451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02518451, "Bioequivalence Evaluation of Two Film-Coated Formulations of Valsartan 160 mg". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02518451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*